Brokerages Set Henry Schein, Inc. (NASDAQ:HSIC) PT at $78.89

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have been assigned an average rating of “Moderate Buy” from the eleven ratings firms that are covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $78.89.

Several research analysts have commented on the company. Evercore ISI boosted their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Finally, Barrington Research reiterated an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th.

Henry Schein Stock Down 2.4 %

Shares of NASDAQ HSIC opened at $68.95 on Tuesday. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.63. The stock’s fifty day moving average is $72.43 and its 200 day moving average is $70.13. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a market capitalization of $8.60 billion, a P/E ratio of 28.37, a PEG ratio of 2.31 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same period last year, the firm earned $1.32 EPS. Sell-side analysts forecast that Henry Schein will post 4.78 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

A number of institutional investors have recently bought and sold shares of the company. American Century Companies Inc. grew its holdings in Henry Schein by 3.1% in the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock worth $351,543,000 after purchasing an additional 162,477 shares during the period. FMR LLC increased its position in Henry Schein by 7.8% in the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after buying an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP raised its stake in Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after buying an additional 600,000 shares during the period. Nuance Investments LLC boosted its holdings in Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after acquiring an additional 414,748 shares in the last quarter. Finally, Burgundy Asset Management Ltd. grew its stake in Henry Schein by 1.0% in the second quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock valued at $105,148,000 after acquiring an additional 16,476 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.